Our aim is to find disease modifying therapies for the diseases that cause dementia.
We’re looking for targets that have been unexplored by the pharmaceutical industry, broadening our focus to novel proteins and pathways implicated in neurodegenerative diseases and will draw on academic expertise to find these.
Have you got an interesting target, implicated in neurodegenerative diseases? We’re keen to hear from you, to help expand our drug discovery portfolio. Find out more about collaborating with us on drug discovery projects.